2017 - 2020 Comprehensive investigations on development, biodistribution, and safety of nanoparticle-loaded dry powder formulations for inhalation with high nanoparticle redispersibility and aerosol performance
2014 - 2018 Development of Novel Dry siRNA Powders for Inhalation Based on Spontaneous Lipid Nanoparticle Constitution in Lung
2011 - 2013 Fate of siRNA in the lungs and optimization of siRNA inhalant formulation based on RNA interference effect
Motoki Sugiura, Tomoyuki Okuda, Emina Yagi, Hirokazu Okamoto. Optimized Molecular Weight of Hydroxypropyl Cellulose in Inhaled Spray-Freeze-Dried Powders for High Deagglomeration and Pulmonary Retention Abilities. Chemical and Pharmaceutical Bulletin. 2026. 74. 1. 55-63
Motoki Sugiura, Tomoyuki Okuda, Hirokazu Okamoto. Development of an inhaled spray-freeze-dried powder composed of methyl cellulose and a dispersion enhancer for prolonged pulmonary drug retention and high aerosol performance. Journal of Pharmaceutical Sciences. 2025. 114. 9. 103907-103907
Tomoyuki OKUDA. Establishment of Fundamental Production Technique for Inhaled High-Dose Dry Powders. Hosokawa Powder Technology Foundation ANNUAL REPORT. 2025
Hirokazu Okamoto, Yuri Takeda, Tomoyuki Okuda. An in vitro analysis of pulmonary deliverability of inhalable solutions and inhalable aerosol products dispersed in ventilator circuit. Aerosol Science and Technology. 2025. 59. 4. 388-401
Takaaki Ito, Tomoyuki Okuda, Seiko Uede, Yuki Kushi, Kohei Tahara, Hirokazu Okamoto. Development of naked pDNA inhalation powder formulation with high transfection efficiency using hyaluronic acid and phenylalanine as excipients. Advanced Powder Technology. 2025. 36. 1. 104750-104750